1. Confo Therapeutics to appoint John Berriman as Chairman of the Board

    Therapeutics, an emerging drug discovery company, today announced the appointment of John Edward Berriman as non-executive director and chairman of the board of directors, starting December 21 ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content

    1. I am delighted to be joining and chairing the board of Confo Therapeutics, whose technology is, I believe, one of the industry's most promising platforms for cracking currently undruggable GPCRs, especially when an agonist is required
  3. Topics Mentioned